
NEONC TECHNOLOGIES HOLDINGS, INC.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
NeOnc Technologies Holdings develops drug delivery technologies and therapeutics for brain and central nervous system cancers, including intranasal delivery methods designed to help drugs cross the blood-brain barrier.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| GARNETT KEITHLYCFO | Buy | $17K | 5,000at $3.36 | Sep 15, 2026 |
| Heshmatpour Amir FCEO, President | Buy | $50K | 9,000at $5.54 | Aug 18, 2026 |
| CHEN THOMAS CCEO | Buy | $70K | 12,757at $5.49 | Aug 18, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable NTHI activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.